Coronavirus (Italy) – From North to South 1039 patients treated with hydroxychloroquine at home. The end result: “Collapse of hospitalisations”

Source: ilfattoquotidiano
“I am a doctor and, positive for Covid19 , I immediately took hydroxychloroquine : in 3-4 days the fever and the other symptoms disappeared “. This is how Paola Varese , head of cancer medicine at the Ovada hospital in Piedmont , begins. “I applied the same protocol on myself that I planned for 276 patients at home,” continues Varese , stressing that “timely intervention by family doctors in patients’ homes is essential, with hydroxychloroquine associated with heparin (and if necessary the ‘ antibiotic ). It is presumable – he says – that the collapse of the hospitalisation is due to the immediate use of the drug : we only had 7 hospitalisations: according to the projected expectations of the ISS we should have had 55 “.

Hydroxychloroquine is one of the treatments against Coronavirus being tested , and is approved by AIFA (Italian Medicines Agency). The pioneer in this field is the Director of Hematology-Oncology of Piacenza, Luigi Cavanna . It was the first in Italy to use it, an intuition that is proving significant . “Since February 25, I have treated 209 patients and in 90% of cases the response has been positive . Hospitalisations have collapsed: from 30% of hospitalised (serious or moderate cases) to less than 5% “. The change, according to Cavanna, came with administration of hydroxychloroquine from the early stages of the disease , when patients were at home, and resulted in the hospitalisation of very few cases in acute conditions. A treatment that, according to preliminary data collected and systematised by 5 different ASLs on 1,039 patients, is working throughout Italy .

Read the original article here: https://www.ilfattoquotidiano.it/2020/04/28/coronavirus-da-nord-a-sud-1039-pazienti-trattati-a-casa-con-idrossiclorochina-il-punto-sulla-sperimentazione-crollo-dei-ricoveri

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »